NEWSLETTER GLOBAL –AUGUST
US, and China Dominate Global Innovation Index (GII) 2024: Top Players in Science and Tech Clusters
The 2024 Global Innovation Index (GII) reveals China and the US as leaders in global science and technology (S&T) clusters. Tokyo-Yokohama (Japan) tops the ranking, followed by Shenzhen-Hong Kong-Guangzhou (China) and Beijing (China). The US features prominently with San Jose–San Francisco leading its clusters at 6th. Notably, China has the most clusters in the top 100, with 26, while the US follows with 20. India makes its mark with four clusters, including Bengaluru at 56th and Delhi at 63rd. Emerging economies like India and Egypt show significant growth, with Indian cities like Bengaluru and Delhi making notable gains. Middle-income economies, particularly in China, exhibited the fastest S&T growth, outpacing high-income clusters. These S&T clusters are crucial in driving innovation and economic development, highlighting the growing importance of emerging economies in the global innovation landscape. The GII underscores the expanding influence of these regions in shaping the future of global technology.
China's State Intellectual Property Office Reports June 2024 Patent Registration Trends
The State Intellectual Property Office released its June 2024 report, revealing a 27.97% year-on-year increase in registered invention patents from January to June. However, utility models and designs saw declines of 12.47% and 11.35%, respectively. The report notes a slight decrease in valid utility models and designs due to deferred patent annuity payments under new regulations. The data, based on applicant nationality and patent holder addresses, reflects ongoing shifts in China’s intellectual property landscape.
ARIPO and CNIPA Initiate Patent Prosecution Highway Pilot to Accelerate Patent Processing
On June 8, 2024, the African Regional Intellectual Property Organization (ARIPO) and the China National Intellectual Property Administration (CNIPA) launched a five-year Patent Prosecution Highway (PPH) pilot program, scheduled to end on June 7, 2029. This collaboration is designed to expedite the patent examination process by allowing applicants whose patent applications have been approved by either ARIPO or CNIPA to request accelerated examination at the other office. Under the PPH program, the second office, known as the Office of Later Examination, can leverage the examination results of the first office, known as the Office of Earlier Examination. This approach minimizes redundant efforts, streamlining the overall patent examination process. The PPH program, which began between the Japan Patent Office (JPO) and the United States Patent and Trademark Office (USPTO) in 2006, has expanded to include 55 intellectual property offices worldwide.
Chinese Courts Set Precedent with Global FRAND Rate Decision in TCL v. Access Advance
In 2024, China has emerged as a pivotal jurisdiction in the global landscape of Standard Essential Patent (SEP) litigation, with its Supreme People’s Court ruling that China has jurisdiction to set a global FRAND (Fair, Reasonable, and Non-Discriminatory) rate for a patent pool. This development, highlighted in TCL’s case against Access Advance, marks China as the first country willing to determine global FRAND terms for patent pools, significantly impacting businesses operating in China. Companies dealing with SEPs in China now face a new legal environment where Chinese courts may dictate global licensing rates, potentially leading to increased scrutiny and stricter enforcement of SEP-related agreements. Businesses must be prepared for heightened legal complexities, including possible challenges to their licensing strategies and the need for more robust compliance with China’s evolving regulatory framework, particularly in the technology sector.
Senate Bill 150 Could Reshape Biosimilar Patent Litigation Landscape in the U.S.
Senate Bill 150, the Affordable Prescriptions for Patients Act of 2023, recently passed by the U.S. Senate, proposes significant amendments to 35 U.S.C. § 271(e) aimed at limiting the number of patents that a reference product sponsor (RPS) can assert in litigation against biosimilar applicants. If enacted, the bill would cap the number of patents an RPS can assert to 20, with additional restrictions on post-listing patents. This change could incentivize biosimilar applicants to engage fully in the “patent dance,” a series of exchanges designed to streamline patent disputes. For RPSs, the amendment would necessitate a strategic re-evaluation of patent portfolios, prioritizing patents with the strongest claims. This legislation could heighten the importance of early disclosure and the tactical selection of patents, potentially reducing the burden of extensive litigation but increasing the stakes of initial patent selections for both parties in biosimilar disputes.
NIST's New AI Guidelines: Implications for U.S. Businesses in Risk Management and Compliance
On July 26, 2024, the U.S. National Institute of Standards and Technology (NIST) issued four guidance documents, including three final versions and one draft, aimed at regulating AI development and implementation. These guidelines, issued under the Biden administration’s AI Executive Order 14110, emphasize risk management, secure development practices, and global AI standards. For businesses operating in the U.S., these documents, while not legally binding, could significantly influence AI strategies. Companies may need to align with these guidelines to mitigate potential liability and insurance risks, especially if involved in federal contracts. The emphasis on secure AI development, managing misuse risks, and adhering to evolving global standards could require companies to reassess their AI practices, ensuring compliance with best practices to avoid reputational and operational risks. Adopting these guidelines may become crucial for maintaining competitiveness and securing trust in the AI-driven marketplace.
Balmuccino LLC v. Starbucks Corp, U.S. District Court, Southern District of New York, No. 24-06214.
Starbucks is facing a third lawsuit from Balmuccino, a company alleging theft of its coffee-flavored lipstick concept. The latest complaint was filed in Manhattan federal court following two previous dismissals on procedural grounds. The plaintiff claims it developed coffee-flavored lip balms in 2016 and pitched the idea to Starbucks in 2018, providing prototypes and confidential information. The meeting was reportedly arranged by TV personality Dr. Mehmet Oz, whose sister-in-law was involved with the Plaintiff. In April 2019, Starbucks launched its “S’mores Frappuccino Sip Kit,” which included lipstick and gloss in four flavors. Balmuccino alleges this was a direct theft of their concept without compensation. The lawsuit seeks unspecified damages and argues that the statute of limitations should be extended due to previous jurisdictional issues. Starbucks has not yet commented on the latest filing. This ongoing legal battle highlights the complexities of intellectual property disputes in the cosmetics and beverage industries.
UKIPO’s Reintroduced IP Advance Scheme Boosts Funding for Start-Ups and SMEs
The UK Intellectual Property Office (UKIPO) has reintroduced its IP Advance scheme, providing crucial financial support for start-ups and SMEs to secure and manage their intellectual property. The scheme offers two funding tiers: up to £2,250 for an IP Audit, which helps businesses assess and strategize their IP, and up to 50% of costs, capped at £2,250, for implementing IP strategies, including patent, trademark, and design applications. To qualify, businesses must meet the UK government’s criteria for micro, small, or medium enterprises and be enrolled in designated business support services like Innovate UK. This initiative not only aids businesses in protecting their valuable IP assets but also ensures they can advance their IP strategies beyond the initial funding, making it a pivotal resource for early-stage companies aiming to solidify their IP positions and foster growth in a competitive market.
EU's NIS2 Directive: Stricter Cybersecurity Rules Impacting Businesses Across Europe
The EU’s Network and Information Security 2 Directive (NIS2), effective from January 2023, sets stricter cybersecurity requirements for organizations providing essential or important services, such as energy, finance, and transport. Companies operating in these sectors must assess their cybersecurity frameworks to comply with NIS2, as non-compliance could lead to significant fines—up to €10 million or 2% of global turnover for essential entities. NIS2 also imposes accountability on management bodies, requiring them to oversee and approve risk management measures, with potential liability for failures. As NIS2 establishes only minimum standards, EU Member States may introduce even stricter measures. Businesses must closely monitor the transposition of NIS2 into national laws, as different countries may impose varying requirements. Organizations operating in multiple EU states should prepare for potential discrepancies in compliance obligations and start early efforts to align with NIS2, ensuring robust cybersecurity practices across their operations.
India Leads Global Pack in Intangible Investment Growth, Signals Economic Shift
India has emerged as a frontrunner in intangible investments, outpacing major economies like the US, France, Germany, and the UK from 2011 to 2020. This rapid growth underscores the significant value creation by Indian companies in areas such as research and development, software, and intellectual property. According to a report in The Times of India on August 10, India ranked 14th among 26 advanced economies in absolute levels of intangible investments in 2020. This places India between Denmark and ahead of Finland and Portugal, a notable achievement for an emerging economy. This trend highlights India’s increasing focus on knowledge-based assets and innovation, potentially signaling a shift in its economic landscape. The growth in intangible investments suggests that Indian companies are increasingly prioritizing areas that drive long-term value and competitiveness in the global market.
NEWSLETTER GLOBAL –AUGUST
India Monthly News Roundup – June & July, 2024
Monthly Roundup | Japan-USA-India | KAFOCUS
Monthly Roundup – India | May 2024
US, and China Dominate Global Innovation Index (GII) 2024: Top Players in Science and Tech Clusters
The 2024 Global Innovation Index (GII) reveals China and the US as leaders in global science and technology (S&T) clusters. Tokyo-Yokohama (Japan) tops the ranking, followed by Shenzhen-Hong Kong-Guangzhou (China) and Beijing (China). The US features prominently with San Jose–San Francisco leading its clusters at 6th. Notably, China has the most clusters in the top 100, with 26, while the US follows with 20. India makes its mark with four clusters, including Bengaluru at 56th and Delhi at 63rd. Emerging economies like India and Egypt show significant growth, with Indian cities like Bengaluru and Delhi making notable gains. Middle-income economies, particularly in China, exhibited the fastest S&T growth, outpacing high-income clusters. These S&T clusters are crucial in driving innovation and economic development, highlighting the growing importance of emerging economies in the global innovation landscape. The GII underscores the expanding influence of these regions in shaping the future of global technology.
China's State Intellectual Property Office Reports June 2024 Patent Registration Trends
The State Intellectual Property Office released its June 2024 report, revealing a 27.97% year-on-year increase in registered invention patents from January to June. However, utility models and designs saw declines of 12.47% and 11.35%, respectively. The report notes a slight decrease in valid utility models and designs due to deferred patent annuity payments under new regulations. The data, based on applicant nationality and patent holder addresses, reflects ongoing shifts in China’s intellectual property landscape.
ARIPO and CNIPA Initiate Patent Prosecution Highway Pilot to Accelerate Patent Processing
On June 8, 2024, the African Regional Intellectual Property Organization (ARIPO) and the China National Intellectual Property Administration (CNIPA) launched a five-year Patent Prosecution Highway (PPH) pilot program, scheduled to end on June 7, 2029. This collaboration is designed to expedite the patent examination process by allowing applicants whose patent applications have been approved by either ARIPO or CNIPA to request accelerated examination at the other office. Under the PPH program, the second office, known as the Office of Later Examination, can leverage the examination results of the first office, known as the Office of Earlier Examination. This approach minimizes redundant efforts, streamlining the overall patent examination process. The PPH program, which began between the Japan Patent Office (JPO) and the United States Patent and Trademark Office (USPTO) in 2006, has expanded to include 55 intellectual property offices worldwide.
Chinese Courts Set Precedent with Global FRAND Rate Decision in TCL v. Access Advance
In 2024, China has emerged as a pivotal jurisdiction in the global landscape of Standard Essential Patent (SEP) litigation, with its Supreme People’s Court ruling that China has jurisdiction to set a global FRAND (Fair, Reasonable, and Non-Discriminatory) rate for a patent pool. This development, highlighted in TCL’s case against Access Advance, marks China as the first country willing to determine global FRAND terms for patent pools, significantly impacting businesses operating in China. Companies dealing with SEPs in China now face a new legal environment where Chinese courts may dictate global licensing rates, potentially leading to increased scrutiny and stricter enforcement of SEP-related agreements. Businesses must be prepared for heightened legal complexities, including possible challenges to their licensing strategies and the need for more robust compliance with China’s evolving regulatory framework, particularly in the technology sector.
Senate Bill 150 Could Reshape Biosimilar Patent Litigation Landscape in the U.S.
Senate Bill 150, the Affordable Prescriptions for Patients Act of 2023, recently passed by the U.S. Senate, proposes significant amendments to 35 U.S.C. § 271(e) aimed at limiting the number of patents that a reference product sponsor (RPS) can assert in litigation against biosimilar applicants. If enacted, the bill would cap the number of patents an RPS can assert to 20, with additional restrictions on post-listing patents. This change could incentivize biosimilar applicants to engage fully in the “patent dance,” a series of exchanges designed to streamline patent disputes. For RPSs, the amendment would necessitate a strategic re-evaluation of patent portfolios, prioritizing patents with the strongest claims. This legislation could heighten the importance of early disclosure and the tactical selection of patents, potentially reducing the burden of extensive litigation but increasing the stakes of initial patent selections for both parties in biosimilar disputes.
NIST's New AI Guidelines: Implications for U.S. Businesses in Risk Management and Compliance
On July 26, 2024, the U.S. National Institute of Standards and Technology (NIST) issued four guidance documents, including three final versions and one draft, aimed at regulating AI development and implementation. These guidelines, issued under the Biden administration’s AI Executive Order 14110, emphasize risk management, secure development practices, and global AI standards. For businesses operating in the U.S., these documents, while not legally binding, could significantly influence AI strategies. Companies may need to align with these guidelines to mitigate potential liability and insurance risks, especially if involved in federal contracts. The emphasis on secure AI development, managing misuse risks, and adhering to evolving global standards could require companies to reassess their AI practices, ensuring compliance with best practices to avoid reputational and operational risks. Adopting these guidelines may become crucial for maintaining competitiveness and securing trust in the AI-driven marketplace.
Balmuccino LLC v. Starbucks Corp, U.S. District Court, Southern District of New York, No. 24-06214.
Starbucks is facing a third lawsuit from Balmuccino, a company alleging theft of its coffee-flavored lipstick concept. The latest complaint was filed in Manhattan federal court following two previous dismissals on procedural grounds. The plaintiff claims it developed coffee-flavored lip balms in 2016 and pitched the idea to Starbucks in 2018, providing prototypes and confidential information. The meeting was reportedly arranged by TV personality Dr. Mehmet Oz, whose sister-in-law was involved with the Plaintiff. In April 2019, Starbucks launched its “S’mores Frappuccino Sip Kit,” which included lipstick and gloss in four flavors. Balmuccino alleges this was a direct theft of their concept without compensation. The lawsuit seeks unspecified damages and argues that the statute of limitations should be extended due to previous jurisdictional issues. Starbucks has not yet commented on the latest filing. This ongoing legal battle highlights the complexities of intellectual property disputes in the cosmetics and beverage industries.
UKIPO’s Reintroduced IP Advance Scheme Boosts Funding for Start-Ups and SMEs
The UK Intellectual Property Office (UKIPO) has reintroduced its IP Advance scheme, providing crucial financial support for start-ups and SMEs to secure and manage their intellectual property. The scheme offers two funding tiers: up to £2,250 for an IP Audit, which helps businesses assess and strategize their IP, and up to 50% of costs, capped at £2,250, for implementing IP strategies, including patent, trademark, and design applications. To qualify, businesses must meet the UK government’s criteria for micro, small, or medium enterprises and be enrolled in designated business support services like Innovate UK. This initiative not only aids businesses in protecting their valuable IP assets but also ensures they can advance their IP strategies beyond the initial funding, making it a pivotal resource for early-stage companies aiming to solidify their IP positions and foster growth in a competitive market.
EU's NIS2 Directive: Stricter Cybersecurity Rules Impacting Businesses Across Europe
The EU’s Network and Information Security 2 Directive (NIS2), effective from January 2023, sets stricter cybersecurity requirements for organizations providing essential or important services, such as energy, finance, and transport. Companies operating in these sectors must assess their cybersecurity frameworks to comply with NIS2, as non-compliance could lead to significant fines—up to €10 million or 2% of global turnover for essential entities. NIS2 also imposes accountability on management bodies, requiring them to oversee and approve risk management measures, with potential liability for failures. As NIS2 establishes only minimum standards, EU Member States may introduce even stricter measures. Businesses must closely monitor the transposition of NIS2 into national laws, as different countries may impose varying requirements. Organizations operating in multiple EU states should prepare for potential discrepancies in compliance obligations and start early efforts to align with NIS2, ensuring robust cybersecurity practices across their operations.
India Leads Global Pack in Intangible Investment Growth, Signals Economic Shift
India has emerged as a frontrunner in intangible investments, outpacing major economies like the US, France, Germany, and the UK from 2011 to 2020. This rapid growth underscores the significant value creation by Indian companies in areas such as research and development, software, and intellectual property. According to a report in The Times of India on August 10, India ranked 14th among 26 advanced economies in absolute levels of intangible investments in 2020. This places India between Denmark and ahead of Finland and Portugal, a notable achievement for an emerging economy. This trend highlights India’s increasing focus on knowledge-based assets and innovation, potentially signaling a shift in its economic landscape. The growth in intangible investments suggests that Indian companies are increasingly prioritizing areas that drive long-term value and competitiveness in the global market.
NEWSLETTER GLOBAL –AUGUST
India Monthly News Roundup – June & July, 2024
Monthly Roundup | Japan-USA-India | KAFOCUS
Monthly Roundup – India | May 2024
NEWSLETTER GLOBAL –AUGUST
US, and China Dominate Global Innovation Index (GII) 2024: Top Players in Science and Tech Clusters
The 2024 Global Innovation Index (GII) reveals China and the US as leaders in global science and technology (S&T) clusters. Tokyo-Yokohama (Japan) tops the ranking, followed by Shenzhen-Hong Kong-Guangzhou (China) and Beijing (China). The US features prominently with San Jose–San Francisco leading its clusters at 6th. Notably, China has the most clusters in the top 100, with 26, while the US follows with 20. India makes its mark with four clusters, including Bengaluru at 56th and Delhi at 63rd. Emerging economies like India and Egypt show significant growth, with Indian cities like Bengaluru and Delhi making notable gains. Middle-income economies, particularly in China, exhibited the fastest S&T growth, outpacing high-income clusters. These S&T clusters are crucial in driving innovation and economic development, highlighting the growing importance of emerging economies in the global innovation landscape. The GII underscores the expanding influence of these regions in shaping the future of global technology.
China's State Intellectual Property Office Reports June 2024 Patent Registration Trends
The State Intellectual Property Office released its June 2024 report, revealing a 27.97% year-on-year increase in registered invention patents from January to June. However, utility models and designs saw declines of 12.47% and 11.35%, respectively. The report notes a slight decrease in valid utility models and designs due to deferred patent annuity payments under new regulations. The data, based on applicant nationality and patent holder addresses, reflects ongoing shifts in China’s intellectual property landscape.
ARIPO and CNIPA Initiate Patent Prosecution Highway Pilot to Accelerate Patent Processing
On June 8, 2024, the African Regional Intellectual Property Organization (ARIPO) and the China National Intellectual Property Administration (CNIPA) launched a five-year Patent Prosecution Highway (PPH) pilot program, scheduled to end on June 7, 2029. This collaboration is designed to expedite the patent examination process by allowing applicants whose patent applications have been approved by either ARIPO or CNIPA to request accelerated examination at the other office. Under the PPH program, the second office, known as the Office of Later Examination, can leverage the examination results of the first office, known as the Office of Earlier Examination. This approach minimizes redundant efforts, streamlining the overall patent examination process. The PPH program, which began between the Japan Patent Office (JPO) and the United States Patent and Trademark Office (USPTO) in 2006, has expanded to include 55 intellectual property offices worldwide.
Chinese Courts Set Precedent with Global FRAND Rate Decision in TCL v. Access Advance
In 2024, China has emerged as a pivotal jurisdiction in the global landscape of Standard Essential Patent (SEP) litigation, with its Supreme People’s Court ruling that China has jurisdiction to set a global FRAND (Fair, Reasonable, and Non-Discriminatory) rate for a patent pool. This development, highlighted in TCL’s case against Access Advance, marks China as the first country willing to determine global FRAND terms for patent pools, significantly impacting businesses operating in China. Companies dealing with SEPs in China now face a new legal environment where Chinese courts may dictate global licensing rates, potentially leading to increased scrutiny and stricter enforcement of SEP-related agreements. Businesses must be prepared for heightened legal complexities, including possible challenges to their licensing strategies and the need for more robust compliance with China’s evolving regulatory framework, particularly in the technology sector.
Senate Bill 150 Could Reshape Biosimilar Patent Litigation Landscape in the U.S.
Senate Bill 150, the Affordable Prescriptions for Patients Act of 2023, recently passed by the U.S. Senate, proposes significant amendments to 35 U.S.C. § 271(e) aimed at limiting the number of patents that a reference product sponsor (RPS) can assert in litigation against biosimilar applicants. If enacted, the bill would cap the number of patents an RPS can assert to 20, with additional restrictions on post-listing patents. This change could incentivize biosimilar applicants to engage fully in the “patent dance,” a series of exchanges designed to streamline patent disputes. For RPSs, the amendment would necessitate a strategic re-evaluation of patent portfolios, prioritizing patents with the strongest claims. This legislation could heighten the importance of early disclosure and the tactical selection of patents, potentially reducing the burden of extensive litigation but increasing the stakes of initial patent selections for both parties in biosimilar disputes.
NIST's New AI Guidelines: Implications for U.S. Businesses in Risk Management and Compliance
On July 26, 2024, the U.S. National Institute of Standards and Technology (NIST) issued four guidance documents, including three final versions and one draft, aimed at regulating AI development and implementation. These guidelines, issued under the Biden administration’s AI Executive Order 14110, emphasize risk management, secure development practices, and global AI standards. For businesses operating in the U.S., these documents, while not legally binding, could significantly influence AI strategies. Companies may need to align with these guidelines to mitigate potential liability and insurance risks, especially if involved in federal contracts. The emphasis on secure AI development, managing misuse risks, and adhering to evolving global standards could require companies to reassess their AI practices, ensuring compliance with best practices to avoid reputational and operational risks. Adopting these guidelines may become crucial for maintaining competitiveness and securing trust in the AI-driven marketplace.
Balmuccino LLC v. Starbucks Corp, U.S. District Court, Southern District of New York, No. 24-06214.
Starbucks is facing a third lawsuit from Balmuccino, a company alleging theft of its coffee-flavored lipstick concept. The latest complaint was filed in Manhattan federal court following two previous dismissals on procedural grounds. The plaintiff claims it developed coffee-flavored lip balms in 2016 and pitched the idea to Starbucks in 2018, providing prototypes and confidential information. The meeting was reportedly arranged by TV personality Dr. Mehmet Oz, whose sister-in-law was involved with the Plaintiff. In April 2019, Starbucks launched its “S’mores Frappuccino Sip Kit,” which included lipstick and gloss in four flavors. Balmuccino alleges this was a direct theft of their concept without compensation. The lawsuit seeks unspecified damages and argues that the statute of limitations should be extended due to previous jurisdictional issues. Starbucks has not yet commented on the latest filing. This ongoing legal battle highlights the complexities of intellectual property disputes in the cosmetics and beverage industries.
UKIPO’s Reintroduced IP Advance Scheme Boosts Funding for Start-Ups and SMEs
The UK Intellectual Property Office (UKIPO) has reintroduced its IP Advance scheme, providing crucial financial support for start-ups and SMEs to secure and manage their intellectual property. The scheme offers two funding tiers: up to £2,250 for an IP Audit, which helps businesses assess and strategize their IP, and up to 50% of costs, capped at £2,250, for implementing IP strategies, including patent, trademark, and design applications. To qualify, businesses must meet the UK government’s criteria for micro, small, or medium enterprises and be enrolled in designated business support services like Innovate UK. This initiative not only aids businesses in protecting their valuable IP assets but also ensures they can advance their IP strategies beyond the initial funding, making it a pivotal resource for early-stage companies aiming to solidify their IP positions and foster growth in a competitive market.
EU's NIS2 Directive: Stricter Cybersecurity Rules Impacting Businesses Across Europe
The EU’s Network and Information Security 2 Directive (NIS2), effective from January 2023, sets stricter cybersecurity requirements for organizations providing essential or important services, such as energy, finance, and transport. Companies operating in these sectors must assess their cybersecurity frameworks to comply with NIS2, as non-compliance could lead to significant fines—up to €10 million or 2% of global turnover for essential entities. NIS2 also imposes accountability on management bodies, requiring them to oversee and approve risk management measures, with potential liability for failures. As NIS2 establishes only minimum standards, EU Member States may introduce even stricter measures. Businesses must closely monitor the transposition of NIS2 into national laws, as different countries may impose varying requirements. Organizations operating in multiple EU states should prepare for potential discrepancies in compliance obligations and start early efforts to align with NIS2, ensuring robust cybersecurity practices across their operations.
India Leads Global Pack in Intangible Investment Growth, Signals Economic Shift
India has emerged as a frontrunner in intangible investments, outpacing major economies like the US, France, Germany, and the UK from 2011 to 2020. This rapid growth underscores the significant value creation by Indian companies in areas such as research and development, software, and intellectual property. According to a report in The Times of India on August 10, India ranked 14th among 26 advanced economies in absolute levels of intangible investments in 2020. This places India between Denmark and ahead of Finland and Portugal, a notable achievement for an emerging economy. This trend highlights India’s increasing focus on knowledge-based assets and innovation, potentially signaling a shift in its economic landscape. The growth in intangible investments suggests that Indian companies are increasingly prioritizing areas that drive long-term value and competitiveness in the global market.
NEWSLETTER GLOBAL –AUGUST
India Monthly News Roundup – June & July, 2024
Monthly Roundup | Japan-USA-India | KAFOCUS
Monthly Roundup – India | May 2024
Connect with our Experts to resolve your legal issues!
KAnalysis is a boutique full service law firm, well positioned to represent its international and domestic clients.
© 2007 – 2024 KAnalysis Consultant Private Limited. All Rights Reserved